Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6925443 | 0.91 | MCHR1 (0.81) | MCHR1HTR2C | |
| SCHEMBL6898082 | 0.89 | MCHR1 (0.78) | MCHR1HTR2C | |
| SCHEMBL6896984 | 0.89 | MCHR1 (0.78) | MCHR1HTR2C | |
| SCHEMBL6926340 | 0.89 | MCHR1 (0.92) | MCHR1HTR2C | |
| SCHEMBL6899093 | 0.87 | MCHR1 (0.93) | MCHR1HTR2C | |
| SCHEMBL6895261 | 0.87 | MCHR1 (0.93) | MCHR1HTR2C | |
| SCHEMBL6898932 | 0.86 | MCHR1 (0.74) | MCHR1HTR2C | |
| SCHEMBL6898474 | 0.86 | MCHR1 (0.74) | MCHR1HTR2C | |
| SCHEMBL6895300 | 0.86 | MCHR1 (0.64) | MCHR1HTR2C | |
| SCHEMBL6894045 | 0.86 | MCHR1 (0.74) | MCHR1HTR2C |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1100485-A4 | SUBSTITUTED ANILIDE COMPOUNDS AND METHODS | SMITHKLINE BEECHAM CORP (US) | 2004-06-09 | — | — | EP | claimed |
| EP-1296671-A2 | GABAPENTIN ANALOGUES FOR SLEEP DISORDERS | WARNER-LAMBERT COMPANY (US) | 2003-04-02 | — | — | EP | claimed |
| JP-2002521436-A | — | — | 2002-07-16 | — | — | JP | claimed |
| WO-2002000209-A2 | GABAPENTIN ANALOGUES FOR SLEEP DISORDERS | WARNER-LAMBERT COMPANY (US) | 2002-01-03 | — | — | WO | claimed |
| EP-1100485-A1 | SUBSTITUTED ANILIDE COMPOUNDS AND METHODS | SMITHKLINE BEECHAM CORPORATION (US) | 2001-05-23 | — | — | EP | claimed |
| WO-2000006146-A9 | SUBSTITUTED ANILIDE COMPOUNDS AND METHODS | SMITHKLINE BEECHAM CORP (US) | 2000-08-03 | — | — | WO | claimed |
| WO-2000006146-A1 | SUBSTITUTED ANILIDE COMPOUNDS AND METHODS | SMITHKLINE BEECHAM CORPORATION (US) | 2000-02-10 | — | — | WO | claimed |
| EP-1480639-A1 | COMBINATIONS OF AN ALPHA-2-DELTA LIGAND WITH A SELECTIVE INHIBITOR OF CYCLOOXYGENASE-2 | Warner-Lambert Company LLC (US) | 2004-12-01 | — | — | EP | disclosed |
| EP-1037649-A4 | POLYMERIC PRODRUGS OF AMINO- AND HYDROXYL-CONTAINING BIOACTIVE AGENTS | ENZON INC (US) | 2004-11-17 | — | — | EP | disclosed |
| EP-1100485-A4 | SUBSTITUTED ANILIDE COMPOUNDS AND METHODS | SMITHKLINE BEECHAM CORP (US) | 2004-06-09 | — | — | EP | disclosed |
| WO-2003070237-A1 | COMBINATIONS OF AN ALPHA-2-DELTA LIGAND WITH A SELECTIVE INHIBITOR OF CYCLOOXYGENASE-2 | WARNER-LAMBERT COMPANY LLC (US) | 2003-08-28 | — | — | WO | disclosed |
| EP-1100485-A1 | SUBSTITUTED ANILIDE COMPOUNDS AND METHODS | SMITHKLINE BEECHAM CORPORATION (US) | 2001-05-23 | — | — | EP | disclosed |
| EP-1037649-A1 | POLYMERIC PRODRUGS OF AMINO- AND HYDROXYL-CONTAINING BIOACTIVE AGENTS | ENZON, INC. (US) | 2000-09-27 | — | — | EP | disclosed |
| WO-2000006146-A9 | SUBSTITUTED ANILIDE COMPOUNDS AND METHODS | SMITHKLINE BEECHAM CORP (US) | 2000-08-03 | — | — | WO | disclosed |
| WO-2000006146-A1 | SUBSTITUTED ANILIDE COMPOUNDS AND METHODS | SMITHKLINE BEECHAM CORPORATION (US) | 2000-02-10 | — | — | WO | disclosed |
| WO-1999030727-A1 | POLYMERIC PRODRUGS OF AMINO- AND HYDROXYL-CONTAINING BIOACTIVE AGENTS | ENZON, INC. (US) | 1999-06-24 | — | — | WO | disclosed |